CELLDEX THERAPEUTICS, Inc. (CLDX) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Join SI Premium – FREE
CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) reported Q3 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.01 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ericsson shares rise as Q1 report reveals strong earnings, gross margin beat
- UnitedHealth Group (UNH) Tops Q1 EPS by 29c, Tops on Revenue; Offers FY24 EPS Guidance
- Ericsson (ERIC) Reports Q1 EPS of SEK0.77; offers outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
